| Literature DB >> 34015087 |
Alana F Ogata1,2,3, Chi-An Cheng1,2,3, Michaël Desjardins3,4,5, Yasmeen Senussi1, Amy C Sherman3,4, Megan Powell4, Lewis Novack4, Salena Von4, Xiaofang Li6, Lindsey R Baden3,4,6, David R Walt1,2,3.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. Eleven of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day 1 after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with production of immunoglobulin G (IgG) and immunoglobulin A (IgA).Entities:
Keywords: COVID-19; SARS-CoV-2 antigens; immune responses; mRNA vaccine; spike
Mesh:
Substances:
Year: 2022 PMID: 34015087 PMCID: PMC8241425 DOI: 10.1093/cid/ciab465
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079